J Van Der Walt
Overview
Explore the profile of J Van Der Walt including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
250
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Van Der Walt J, Parker R
S Afr Med J
. 2024 Mar;
113(11):22-26.
PMID: 38525640
Healthcare providers face the challenging task of managing patients who suffer from chronic nociplastic pain conditions. Pain is a multidimensional experience, and the current approach to managing people in chronic...
2.
Day C, Van Der Walt J, Crombie K, Hendrikse C, Peter J
S Afr Med J
. 2023 Oct;
113(8):51-57.
PMID: 37882115
Background: Angioedema is the most common acute allergic presentation to emergency centres (EC), with hospitalisation rates increasing in high-income countries. Angioedema can complicate with life-threatening laryngeal obstruction. There are no...
3.
Day C, Deetlefs M, OBrien A, Smith J, Boyd M, Embling N, et al.
S Afr Med J
. 2023 Feb;
113(2):69-74.
PMID: 36757070
Background: Up to a quarter of inpatients in high-income countries (HICs) self-report beta-lactam allergy (BLA), which if incorrect,increases the use of alternative antibiotics, worsening individual health outcomes and driving bacterial...
4.
Van der Spuy K, Crowther M, Nejthardt M, Roodt F, Davids J, Roos J, et al.
S Afr Med J
. 2018 Jul;
108(7):590-595.
PMID: 30004348
Background: Hypertension is common, affecting over one billion people worldwide. In sub-Saharan Africa, hypertensive disease not only affects the older population but is becoming increasingly prevalent in younger individuals. In...
5.
Abdallah H, Abramowski A, Aharonian F, Benkhali F, Anguner E, Arakawa M, et al.
Phys Rev Lett
. 2018 Jun;
120(20):201101.
PMID: 29864326
Spectral lines are among the most powerful signatures for dark matter (DM) annihilation searches in very-high-energy γ rays. The central region of the Milky Way halo is one of the...
6.
Abdalla H, Abramowski A, Aharonian F, Benkhali F, Akhperjanian A, Andersson T, et al.
Phys Rev Lett
. 2016 Oct;
117(15):151302.
PMID: 27768338
Results: No significant excess associated with dark matter annihilations was found in the energy range of 100 GeV to 2 TeV and upper limits on the gamma-ray flux and the...
7.
Abdallah H, Abramowski A, Aharonian F, Benkhali F, Akhperjanian A, Anguner E, et al.
Phys Rev Lett
. 2016 Sep;
117(11):111301.
PMID: 27661677
The inner region of the Milky Way halo harbors a large amount of dark matter (DM). Given its proximity, it is one of the most promising targets to look for...
8.
Blauvelt A, Puig L, Chimenti S, Vender R, Rajagopalan M, Romiti R, et al.
Br J Dermatol
. 2016 Sep;
177(1):23-33.
PMID: 27639072
Biosimilars are drugs that are similar, but not identical, to originator biologics. Preclinical analytical studies are required to show similarity on a molecular and structural level, but efficacy and safety...
9.
Blauvelt A, Cohen A, Puig L, Vender R, Van Der Walt J, Wu J
Br J Dermatol
. 2015 Nov;
174(2):282-6.
PMID: 26522054
Biosimilars, sometimes called 'generic biologics', are no longer a vision for the future but a present-day reality. Drug manufacturers and regulatory authorities are charged with ensuring that these products are...
10.
Torlakovic E, Naresh K, Kremer M, Van Der Walt J, Hyjek E, Porwit A
J Clin Pathol
. 2009 May;
62(6):547-51.
PMID: 19474355
Background And Aims: In diagnostic immunohistochemistry (IHC), daily quality control/quality assurance measures (QC/QA) and participation in external quality assurance programmes (EQA) are important in ensuring good laboratory practice and patient...